2m 2m 2m 2m 2m 2m 2m
COLLPLANT BIOT (CLGN)
NASDAQ
$0.40-$0.005 (-1.27%)
Price as of Jun 03, 2026 7:04 PM EDT- $4.3MMarket Cap
- -84.25%1-Year Change
- BiotechnologyIndustry
COLLPLANT BIOT (CLGN)
$0.40-$0.005 (-1.27%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.4M +360.39% | 515,000 -95.30% | 11.0M +3,565.22% | 299,000 -98.09% | |
Cost of Revenue | 835,000 -48.62% | 1.6M -18.38% | 2.0M +397.75% | 400,000 -80.05% | |
Gross Profit | 1.5M +238.38% | -1.1M -112.38% | 9.0M +8,979.21% | -101,000 -100.74% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -8.2M -22.14% | -10.5M +0.30% | -10.5M +2.23% | -10.3M +34.39% | |
Depreciation and Amortization Expense | 912,000 -12.14% | 1.0M -5.81% | 1.1M +2.42% | 1.1M +39.20% | |
Total Operating Expenses | 4.8M -14.11% | 5.6M -6.17% | 6.0M -11.05% | 6.7M +13.48% | |
Operating Profit | -11.5M -33.44% | -17.3M +129.65% | -7.5M -56.06% | -17.1M -26,403.08% | |
Interest Income | 380,000 -48.51% | 738,000 -6.35% | 788,000 N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 380,000 -48.51% | 738,000 -6.35% | 788,000 N/A | 0 N/A | |
Total Nonoperating Income and Expense | -6,000 -100.93% | 642,000 +30.22% | 493,000 +186.63% | 172,000 0.00% | |
Income before Taxes | -11.5M -33.44% | -17.3M +129.65% | -7.5M -56.06% | -17.1M -26,403.08% | |
Income Taxes | N/A N/A | 35.2M -41.26% | 60.0M N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -11.5M -30.83% | -16.6M +136.63% | -7.0M -58.53% | -16.9M -7,241.35% | |
Net Income from Continuing Operations Applicable to Common | -11.5M -30.83% | -16.6M +136.63% | -7.0M -58.53% | -16.9M -7,241.35% | |
Basic EPS and Net Income | -0.94 -35.17% | -1.45 +133.87% | -0.62 -59.48% | -1.53 -7,750.00% | |
Diluted EPS and Net Income | -0.94 -35.17% | -1.45 +133.87% | -0.62 -59.48% | -1.53 -7,750.00% | |
Basic Weighted Average Shares | 12.2M +6.54% | 11.5M +0.57% | 11.4M +3.23% | 11.0M +10.68% | |
Diluted Weighted Average Shares | 12.2M +6.54% | 11.5M +0.57% | 11.4M +3.23% | 11.0M -7.80% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.6M -53.05% | 11.9M -55.35% | 26.7M -10.05% | 29.7M +125.53% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 5.6M -53.05% | 11.9M -55.35% | 26.7M -10.05% | 29.7M +125.53% | |
Total Current Assets | 6.7M -48.81% | 13.2M -52.97% | 28.0M -11.49% | 31.7M -29.78% | |
Accumulated Depreciation | 7.9M +12.16% | 7.0M +16.18% | 6.0M +19.94% | 5.0M +25.62% | |
Property and Plant and Equipment and Net | 1.5M -36.11% | 2.3M -17.89% | 2.8M -5.97% | 3.0M +8.72% | |
Total Long-Term Assets | 4.0M -26.98% | 5.5M -9.40% | 6.1M -0.10% | 6.1M -0.44% | |
Total Assets | 10.8M -42.36% | 18.7M -45.17% | 34.1M -9.64% | 37.8M -26.27% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 321,000 +46.58% | |
Total Current Liabilities | 2.7M -10.03% | 3.0M -8.64% | 3.3M +4.70% | 3.1M +3.02% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 6.5M +21,566.67% | |
Total Long-Term Liabilities | 2.0M -10.68% | 2.3M -10.26% | 2.5M +6.42% | 2.4M -22.89% | |
Total Liabilities | 4.7M -10.31% | 5.2M -9.35% | 5.8M +5.45% | 5.5M -10.09% | |
Retained Earnings | -124.8M +10.14% | -113.3M +17.17% | -96.7M +7.82% | -89.7M +23.25% | |
Total Stockholders Equity | 6.1M -54.84% | 13.5M -52.49% | 28.3M -12.21% | 32.3M -28.46% | |
Total Shares Outstanding | 12.8M +11.77% | 11.5M +0.02% | 11.5M +6.32% | 10.8M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -9.4M -33.17% | -14.1M +410.06% | -2.8M -79.83% | -13.7M -647.70% | |
Capital Expenditures | 28,000 -94.20% | 483,000 -49.37% | 954,000 -25.12% | 1.3M -10.78% | |
Cash from Investing Activities | -27,000 -94.99% | -539,000 -53.37% | -1.2M -104.00% | 28.9M +191.65% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 3.1M +34,366.67% | 9,000 -99.19% | 1.1M -40.88% | 1.9M -95.17% | |
Financials Ratio | |||||
Gross Margin | 64.78% +130.06% | -215.53% -363.38% | 81.83% +342.26% | -33.78% -138.75% | |
Operating Margin | -484.31% -85.54% | -3,349.71% +4,786.78% | -68.55% -98.80% | -5,718.06% -1,375,956.64% | |
Return on Assets | -77.90% +23.91% | -62.87% +221.98% | -19.53% -48.67% | -38.04% -5,080.63% | |
Return on Equity | -117.56% +47.95% | -79.46% +243.13% | -23.16% -47.05% | -43.73% -4,675.99% | |
Revenue Growth | 360.39% +478.16% | -95.30% -102.67% | 3,565.22% +3,734.70% | -98.09% -163.34% | |
Current Ratio | 2.53 -43.10% | 4.44 -48.52% | 8.62 -15.46% | 10.20 -31.84% | |
Cash Ratio | 2.09 -47.82% | 4.01 -51.13% | 8.20 -14.09% | 9.55 +118.92% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.21 +3,741.82% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.18 +3,585.71% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow